• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症:从突变的亨廷顿蛋白到神经营养因子疗法

Huntington's Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy.

作者信息

Sari Youssef

机构信息

Department of Pharmacology, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, USA.

出版信息

Int J Biomed Sci. 2011 Jun;7(2):89-100.

PMID:21841917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3154262/
Abstract

Huntington's disease (HD) is an inherited disorder characterized by neuronal dysfunction and degeneration in striatum and cerebral cortex. Although the signaling pathways involved in HD are not yet clearly elucidated, mutant huntingtin protein is a key factor in the induction of neurodegeneration. The mutant huntingtin protein alters intracellular Ca(2+) homeostasis, disrupts intracellular trafficking and impairs gene transcription. In this review, I emphasize the effects of mutant huntingtin protein in Ca(2+) handling and transcriptional factors. Transcriptional alterations are key factors in the deficits of several proteins involved in the cellular machinery. These proteins include neurotrophic factors such as brain-derived neurotrophic factor, fibroblast growth factor, glial-cell-line-derived neurotrophic factor, ciliary neurotrophic factor and neurturin that have been suggested to restore neuronal dysfunction, improve behavioral deficits and prolong the survival in animal models of HD. An understanding of the molecular pathways involved in neurodegeneration will shed light on the choice of neurotrophic factors targeting a specific neuronal population in HD and will consequently overcome behavioral deficits.

摘要

亨廷顿舞蹈症(HD)是一种遗传性疾病,其特征是纹状体和大脑皮质中的神经元功能障碍和退化。尽管尚未明确阐明HD所涉及的信号通路,但突变型亨廷顿蛋白是诱导神经退行性变的关键因素。突变型亨廷顿蛋白会改变细胞内Ca(2+)稳态,破坏细胞内运输并损害基因转录。在本综述中,我着重阐述突变型亨廷顿蛋白在Ca(2+)处理和转录因子方面的作用。转录改变是细胞机制中几种蛋白质缺陷的关键因素。这些蛋白质包括神经营养因子,如脑源性神经营养因子、成纤维细胞生长因子、胶质细胞系源性神经营养因子、睫状神经营养因子和神经营养素,它们已被建议用于恢复HD动物模型中的神经元功能障碍、改善行为缺陷并延长生存期。对神经退行性变所涉及分子途径的理解将有助于在HD中选择针对特定神经元群体的神经营养因子,从而克服行为缺陷。

相似文献

1
Huntington's Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy.亨廷顿舞蹈症:从突变的亨廷顿蛋白到神经营养因子疗法
Int J Biomed Sci. 2011 Jun;7(2):89-100.
2
Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.下调与突触功能相关的神经胶质基因可减轻亨廷顿病的发病机制。
Elife. 2021 Apr 19;10:e64564. doi: 10.7554/eLife.64564.
3
Potential drugs and methods for preventing or delaying the progression of Huntington's disease.预防或延缓亨廷顿舞蹈病进展的潜在药物和方法。
Recent Pat CNS Drug Discov. 2011 May 1;6(2):80-90. doi: 10.2174/157488911795933884.
4
Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease.在亨廷顿舞蹈病大鼠模型中,神经营养因子对纹状体投射神经元具有保护作用,但对中间神经元无此作用。
Neuroscience. 2000;98(1):89-96. doi: 10.1016/s0306-4522(00)00074-9.
5
Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.亨廷顿病相关行为、细胞和病理特征的促进:亨廷顿病基因缺失在神经节内侧和外侧谱系中差异破坏区域中间神经元和投射神经元亚型。
J Neurosci. 2019 Mar 6;39(10):1892-1909. doi: 10.1523/JNEUROSCI.2443-18.2018. Epub 2019 Jan 9.
6
Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.在亨廷顿舞蹈症小鼠模型中,通过病毒递送胶质细胞源性神经营养因子可改善行为并保护纹状体神经元。
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9345-50. doi: 10.1073/pnas.0508875103. Epub 2006 Jun 2.
7
Mutant Huntingtin Impairs BDNF Release from Astrocytes by Disrupting Conversion of Rab3a-GTP into Rab3a-GDP.突变型亨廷顿蛋白通过破坏Rab3a-GTP向Rab3a-GDP的转化,损害星形胶质细胞释放脑源性神经营养因子。
J Neurosci. 2016 Aug 24;36(34):8790-801. doi: 10.1523/JNEUROSCI.0168-16.2016.
8
Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice.自愿性体育锻炼对亨廷顿舞蹈病转基因小鼠行为和脑源性神经营养因子表达缺陷的不同影响。
Neuroscience. 2006 Aug 25;141(2):569-584. doi: 10.1016/j.neuroscience.2006.04.013. Epub 2006 May 22.
9
Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.饮食限制可使亨廷顿蛋白突变小鼠的葡萄糖代谢和脑源性神经营养因子(BDNF)水平正常化,减缓疾病进展,并延长生存期。
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2911-6. doi: 10.1073/pnas.0536856100. Epub 2003 Feb 14.
10
Neurotrophic factors in Huntington's disease.亨廷顿舞蹈症中的神经营养因子
Prog Brain Res. 2004;146:195-229. doi: 10.1016/s0079-6123(03)46014-7.

引用本文的文献

1
Durable silencing using non-evolved dCas9 epigenome editors in patient-derived cells.在患者来源的细胞中使用未进化的dCas9表观基因组编辑器实现持久沉默。
Mol Ther Nucleic Acids. 2025 May 14;36(2):102561. doi: 10.1016/j.omtn.2025.102561. eCollection 2025 Jun 10.
2
Role of Fibroblast Growth Factors in Neurological Disorders: Insight into Therapeutic Approaches and Molecular Mechanisms.成纤维细胞生长因子在神经疾病中的作用:对治疗方法和分子机制的深入了解
Mol Neurobiol. 2025 Apr 26. doi: 10.1007/s12035-025-04962-x.
3
Navigating triplet repeats sequencing: concepts, methodological challenges and perspective for Huntington's disease.

本文引用的文献

1
Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease.头孢曲松诱导亨廷顿病 R6/2 模型皮质和纹状体 GLT1 的上调。
J Biomed Sci. 2010 Jul 27;17(1):62. doi: 10.1186/1423-0127-17-62.
2
The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.亨廷顿病中线粒体功能障碍与转录失调的相互关系。
J Bioenerg Biomembr. 2010 Jun;42(3):199-205. doi: 10.1007/s10863-010-9286-7.
3
pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking.
解读三联体重复序列测序:概念、方法学挑战及亨廷顿舞蹈症研究前景
Nucleic Acids Res. 2025 Jan 7;53(1). doi: 10.1093/nar/gkae1155.
4
Drosophila glial system: an approach towards understanding molecular complexity of neurodegenerative diseases.果蝇神经胶质系统:理解神经退行性疾病分子复杂性的一种方法。
Mol Biol Rep. 2024 Nov 13;51(1):1146. doi: 10.1007/s11033-024-10075-w.
5
Palmitoylethanolamide, an endogenous fatty acid amide, and its pleiotropic health benefits: A narrative review.棕榈酰乙醇胺,一种内源性脂肪酸酰胺及其多效性健康益处:一篇叙述性综述。
J Biomed Res. 2024 Oct 22;39(3):215-228. doi: 10.7555/JBR.38.20240053.
6
Functional Characterisation of the Circular RNA, , in Huntington's Disease.环状 RNA , 在亨廷顿病中的功能特征。
Cells. 2023 May 7;12(9):1337. doi: 10.3390/cells12091337.
7
Computational insights into missense mutations in HTT gene causing Huntington's disease and its interactome networks.计算对引起亨廷顿病的 HTT 基因突变及其互作网络的深入了解。
Ir J Med Sci. 2023 Jun;192(3):1435-1445. doi: 10.1007/s11845-022-03043-5. Epub 2022 Jul 13.
8
The Interaction of and in Neurogenesis and Its Implication in Neurodegenerative Diseases.和在神经发生中的相互作用及其在神经退行性疾病中的意义。
Cells. 2022 Jun 28;11(13):2048. doi: 10.3390/cells11132048.
9
The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors.犬尿氨酸途径和犬尿氨酸 3-单加氧酶抑制剂。
Molecules. 2022 Jan 2;27(1):273. doi: 10.3390/molecules27010273.
10
Potential role of TrkB agonist in neuronal survival by promoting CREB/BDNF and PI3K/Akt signaling in vitro and in vivo model of 3-nitropropionic acid (3-NP)-induced neuronal death.体外和体内 3-硝基丙酸(3-NP)诱导神经元死亡模型中,TrkB 激动剂通过促进 CREB/BDNF 和 PI3K/Akt 信号转导促进神经元存活的潜在作用。
Apoptosis. 2021 Feb;26(1-2):52-70. doi: 10.1007/s10495-020-01645-x. Epub 2020 Nov 23.
PARIS-htt:一个优化的亨廷顿蛋白表达平台,用于研究囊泡运输所需的功能结构域。
Mol Brain. 2010 Jun 1;3:17. doi: 10.1186/1756-6606-3-17.
4
Mitochondrial matters in Huntington disease.亨廷顿病中的线粒体问题。
J Bioenerg Biomembr. 2010 Jun;42(3):189-91. doi: 10.1007/s10863-010-9291-x.
5
Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expression.亨廷顿病基因敲入纹状体细胞中TrkB介导的ERK1/2激活受损涉及p52/p46 Shc表达降低。
J Biol Chem. 2010 Jul 9;285(28):21537-48. doi: 10.1074/jbc.M109.084202. Epub 2010 May 4.
6
Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.亨廷顿病中线粒体功能障碍的性质和原因:重点关注亨廷顿蛋白和纹状体。
J Neurochem. 2010 Jul;114(1):1-12. doi: 10.1111/j.1471-4159.2010.06741.x. Epub 2010 Apr 9.
7
Huntington's disease: pathogenesis to animal models.亨廷顿病:从发病机制到动物模型。
Pharmacol Rep. 2010 Jan-Feb;62(1):1-14. doi: 10.1016/s1734-1140(10)70238-3.
8
The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease.亨廷顿病发病机制中天冬酰胺酰基内肽酶切割亨廷顿蛋白的翻译后修饰作用
Neurosci Bull. 2010 Apr;26(2):153-62. doi: 10.1007/s12264-010-1118-6.
9
Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.亨廷顿病中神经元的差异易损性:细胞类型特异性特征的作用。
J Neurochem. 2010 Jun;113(5):1073-91. doi: 10.1111/j.1471-4159.2010.06672.x. Epub 2010 Mar 17.
10
Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.外源性给予 GDNF 可维持亨廷顿病转基因小鼠模型的运动功能并防止神经元丢失。
Exp Neurol. 2010 Jul;224(1):155-62. doi: 10.1016/j.expneurol.2010.03.005. Epub 2010 Mar 19.